These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38890421)

  • 1. Structure-guided conversion from an anaplastic lymphoma kinase inhibitor into Plasmodium lysyl-tRNA synthetase selective inhibitors.
    Zhou J; Xia M; Huang Z; Qiao H; Yang G; Qian Y; Li P; Zhang Z; Gao X; Jiang L; Wang J; Li W; Fang P
    Commun Biol; 2024 Jun; 7(1):742. PubMed ID: 38890421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor.
    Zhou J; Huang Z; Zheng L; Hei Z; Wang Z; Yu B; Jiang L; Wang J; Fang P
    Nucleic Acids Res; 2020 Nov; 48(20):11566-11576. PubMed ID: 33053158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
    Chhibber-Goel J; Yogavel M; Sharma A
    Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of malaria-parasite lysyl-tRNA synthetase provides a platform for drug development.
    Khan S; Garg A; Camacho N; Van Rooyen J; Kumar Pole A; Belrhali H; Ribas de Pouplana L; Sharma V; Sharma A
    Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):785-95. PubMed ID: 23633587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic Resolution Analyses of Isocoumarin Derivatives for Inhibition of Lysyl-tRNA Synthetase.
    Zhou J; Zheng L; Hei Z; Li W; Wang J; Yu B; Fang P
    ACS Chem Biol; 2020 Apr; 15(4):1016-1025. PubMed ID: 32195573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin.
    Hoepfner D; McNamara CW; Lim CS; Studer C; Riedl R; Aust T; McCormack SL; Plouffe DM; Meister S; Schuierer S; Plikat U; Hartmann N; Staedtler F; Cotesta S; Schmitt EK; Petersen F; Supek F; Glynne RJ; Tallarico JA; Porter JA; Fishman MC; Bodenreider C; Diagana TT; Movva NR; Winzeler EA
    Cell Host Microbe; 2012 Jun; 11(6):654-63. PubMed ID: 22704625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Synthesis of Metabolically Stable tRNA Synthetase Inhibitors Derived from Cladosporin.
    Rusch M; Thevenon A; Hoepfner D; Aust T; Studer C; Patoor M; Rollin P; Livendahl M; Ranieri B; Schmitt E; Spanka C; Gademann K; Bouchez LC
    Chembiochem; 2019 Mar; 20(5):644-649. PubMed ID: 30462880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Plasmodium falciparum Lysyl-tRNA Synthetase via a Piperidine-Ring Scaffold Inspired Cladosporin Analogues.
    Babbar P; Sato M; Manickam Y; Mishra S; Harlos K; Gupta S; Parvez S; Kikuchi H; Sharma A
    Chembiochem; 2021 Jul; 22(14):2468-2477. PubMed ID: 33969584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.
    Hoen R; Novoa EM; López A; Camacho N; Cubells L; Vieira P; Santos M; Marin-Garcia P; Bautista JM; Cortés A; Ribas de Pouplana L; Royo M
    Chembiochem; 2013 Mar; 14(4):499-509. PubMed ID: 23444099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for Specific Inhibition of tRNA Synthetase by an ATP Competitive Inhibitor.
    Fang P; Han H; Wang J; Chen K; Chen X; Guo M
    Chem Biol; 2015 Jun; 22(6):734-44. PubMed ID: 26074468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.
    Baragaña B; Forte B; Choi R; Nakazawa Hewitt S; Bueren-Calabuig JA; Pisco JP; Peet C; Dranow DM; Robinson DA; Jansen C; Norcross NR; Vinayak S; Anderson M; Brooks CF; Cooper CA; Damerow S; Delves M; Dowers K; Duffy J; Edwards TE; Hallyburton I; Horst BG; Hulverson MA; Ferguson L; Jiménez-Díaz MB; Jumani RS; Lorimer DD; Love MS; Maher S; Matthews H; McNamara CW; Miller P; O'Neill S; Ojo KK; Osuna-Cabello M; Pinto E; Post J; Riley J; Rottmann M; Sanz LM; Scullion P; Sharma A; Shepherd SM; Shishikura Y; Simeons FRC; Stebbins EE; Stojanovski L; Straschil U; Tamaki FK; Tamjar J; Torrie LS; Vantaux A; Witkowski B; Wittlin S; Yogavel M; Zuccotto F; Angulo-Barturen I; Sinden R; Baum J; Gamo FJ; Mäser P; Kyle DE; Winzeler EA; Myler PJ; Wyatt PG; Floyd D; Matthews D; Sharma A; Striepen B; Huston CD; Gray DW; Fairlamb AH; Pisliakov AV; Walpole C; Read KD; Van Voorhis WC; Gilbert IH
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7015-7020. PubMed ID: 30894487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysyl-tRNA synthetase-generated lysyl-adenylate is a substrate for histidine triad nucleotide binding proteins.
    Chou TF; Wagner CR
    J Biol Chem; 2007 Feb; 282(7):4719-4727. PubMed ID: 17158446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of malaria parasite lysyl-tRNA synthetase inhibition by cladosporin.
    Khan S; Sharma A; Belrhali H; Yogavel M; Sharma A
    J Struct Funct Genomics; 2014 Jun; 15(2):63-71. PubMed ID: 24935905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
    Xie SC; Metcalfe RD; Dunn E; Morton CJ; Huang SC; Puhalovich T; Du Y; Wittlin S; Nie S; Luth MR; Ma L; Kim MS; Pasaje CFA; Kumpornsin K; Giannangelo C; Houghton FJ; Churchyard A; Famodimu MT; Barry DC; Gillett DL; Dey S; Kosasih CC; Newman W; Niles JC; Lee MCS; Baum J; Ottilie S; Winzeler EA; Creek DJ; Williamson N; Parker MW; Brand S; Langston SP; Dick LR; Griffin MDW; Gould AE; Tilley L
    Science; 2022 Jun; 376(6597):1074-1079. PubMed ID: 35653481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.
    Saint-Léger A; Sinadinos C; Ribas de Pouplana L
    Bioengineered; 2016 Apr; 7(2):60-4. PubMed ID: 26963157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toolkit of Approaches To Support Target-Focused Drug Discovery for
    Milne R; Wiedemar N; Corpas-Lopez V; Moynihan E; Wall RJ; Dawson A; Robinson DA; Shepherd SM; Smith RJ; Hallyburton I; Post JM; Dowers K; Torrie LS; Gilbert IH; Baragaña B; Patterson S; Wyllie S
    ACS Infect Dis; 2022 Sep; 8(9):1962-1974. PubMed ID: 36037410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoacyl tRNA synthetases as malarial drug targets: a comparative bioinformatics study.
    Nyamai DW; Tastan Bishop Ö
    Malar J; 2019 Feb; 18(1):34. PubMed ID: 30728021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of Pfmrk, a Plasmodium falciparum CDK, by antimalarial 1,3-diaryl-2-propenones.
    Geyer JA; Keenan SM; Woodard CL; Thompson PA; Gerena L; Nichols DA; Gutteridge CE; Waters NC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1982-5. PubMed ID: 19250824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.